![6-Month Glucose Implant Sensor Receives CE Mark Approval [video]](https://i0.wp.com/healthtechinsider.com/wp-content/uploads/Eversense_CGM_with_video_600x275.jpg?resize=600%2C276&ssl=1)
by Bruce Brown | June 30, 2022 | Medical
Following FDA clearance for its long-lasting Eversense E3 CGM System (continuous glucose monitoring) earlier this year, Senseonics’ Ascensia Diabetes Care division announced CE Mark approval for the platform. Alfred Poor first wrote about FDA approval for the...
